# Coherus Biosciences

Coherus Biosciences is an Asset Manager based in Redwood City, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Redwood City, United States
- **Region:** North America
- **Address:** 333 Twin Dolphin Drive Suite 600, Redwood City, CA 94065, United States
- **Assets under management:** Undisclosed
- **Website:** coherus.com

## Regulatory record

- **Reports private funds:** No

## About

Coherus Oncology is a commercial-stage company advancing next-generation combination therapies to elevate what’s possible for people living with cancer.

## Sectors

- Healthcare Services

## Offices

- Camarillo, CA, United States

## Questions

### What is Coherus Biosciences' primary therapeutic focus?

The firm is focused exclusively on immuno-oncology, developing combination therapies designed to overcome immune resistance in cancer. Its pipeline includes multiple clinical-stage candidates that target the tumor microenvironment. This specialization is underpinned by its commercial-stage asset LOQTORZI, an FDA-approved treatment for nasopharyngeal carcinoma.

### Does Coherus Biosciences operate as a fund or an operating company?

Coherus is a commercial-stage operating biotechnology company, not an investment fund. It manages its own drug development, clinical trials, regulatory approvals, and commercial sales in-house. Capital allocation is directed toward advancing its internal pipeline rather than deploying into external portfolio companies.

### What is LOQTORZI and why is it significant for Coherus?

LOQTORZI (toripalimab-tpzi) is Coherus's approved immuno-oncology therapy and the only FDA-approved drug for recurrent, advanced or metastatic nasopharyngeal carcinoma. It can be administered in combination with chemotherapy or as a single agent. As the company's core commercial product, LOQTORZI serves as the revenue foundation that supports additional pipeline development.

### What stages of drug development does Coherus pursue?

Coherus advances both commercial and clinical-stage assets. Its pipeline consists of investigational immuno-oncology candidates currently in clinical trials across multiple cancer indications. The company has not publicly segmented its portfolio by Phase I, II, or III designations in a detailed pipeline chart, but its disclosures confirm active clinical-stage programs targeting the tumor microenvironment.

### Where does Coherus Biosciences maintain operations?

The company's headquarters is located at 333 Twin Dolphin Drive in Redwood City, California, with a second office in Camarillo, California. These two US locations house its commercial, clinical, and administrative functions.

## Related profiles

- [Moon Capital Management](https://altss.com/profile/moon-capital-management)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/coherus-biosciences

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology